Copyright
©The Author(s) 2022.
World J Clin Cases. Jun 26, 2022; 10(18): 6307-6313
Published online Jun 26, 2022. doi: 10.12998/wjcc.v10.i18.6307
Published online Jun 26, 2022. doi: 10.12998/wjcc.v10.i18.6307
Features | Non-metastatic (n = 34) | Metastatic (n = 7) |
Age (yr), mean ± SD (range) | 41.7 ± 17 (10-83) | 42.6 ± 14 (27-68) |
Female sex | 18/33 (55%; 1 unknown) | 4/7 (57%) |
Clinical presentation | ||
Incidental | 24 (71%) | 4 (57%) |
Flank pain/haematuria | 10 (29%) | 3 (43%) |
History of malignancy (other sites) | 8 (24%) | 1 (14%) |
Tumour characteristics | ||
Size (cm), mean ± SD (range) | 4.2 ± 2.3 (1.1-11.8) | 5.3 ± 2.3 (3.5-10) |
Right/left sided | 17/16 (1 unknown) | 5 2 |
Necrosis | 9 (24%) | 3 (43%) |
Ki-67 proliferation index | 1% to 30% (n = 6) | 6% (n = 1) |
pT stage | ||
1a | 20 | 3 |
1b | 10 | 3 |
2a | 1 | 0 |
2b | 2 | 0 |
Immunohistochemical features | ||
CK7 | 24/25 (96%) | 5/6 (83%) |
CK20 | 3/14 (21%) | 2/4 (50%) |
CD10 | 4/23 (17%) | 1/5 (20%) |
Vimentin | 20/25 (80%) | 3/4 (75%) |
PAX8 | 10/11 (91%) | 3/4 (75%) |
Site of metastasis | - | Bone (2), lung (3), lymph node (2) |
Follow-up period (mo) | 22.1 ± 19.8 | 30.6 ± 28.8 |
Disease/death at follow-up | 0 | 2 (28%) |
- Citation: Wu SC, Li XY, Liao BJ, Xie K, Chen WM. Thyroid follicular renal cell carcinoma excluding thyroid metastases: A case report . World J Clin Cases 2022; 10(18): 6307-6313
- URL: https://www.wjgnet.com/2307-8960/full/v10/i18/6307.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i18.6307